Medicinal Chemists are specialized scientists focused on the design, synthesis, and development of chemical compounds that can become pharmaceutical drugs. Their work bridges the gap between chemistry and pharmacology, applying principles of organic chemistry to develop molecules that interact with biological systems in therapeutic ways. Medicinal chemists are responsible for optimizing the chemical properties of compounds to improve their effectiveness, stability, and bioavailability. Their goal is to identify molecules that can target specific biological pathways or diseases while minimizing side effects. Through techniques like structure-activity relationship (SAR) analysis, they refine drug candidates to meet the necessary criteria for preclinical and clinical testing. Medicinal chemists are also crucial in addressing emerging healthcare challenges, such as the development of drugs for antibiotic-resistant infections.
Medicinal chemists work closely with pharmacologists, toxicologists, and formulation scientists to ensure the drug candidates are suitable for development. They are involved in every step of the drug discovery process, from the initial hit identification through to lead optimization and scale-up for clinical trials. These chemists also tackle challenges like drug resistance and metabolic degradation, working to create more potent, long-lasting therapies. With the rise of personalized medicine, medicinal chemists are increasingly focused on developing drugs tailored to individual genetic profiles. Their expertise remains essential in driving forward the discovery and development of new, life-saving therapies.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia